ArticleCancers2022

An Integrative Clinical Model for the Prediction of Pathological Complete Response in Patients with Operable Stage II and Stage III Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy.

Wai-Shan Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.